| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $3,819,715 ) |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 2 | NIH | 12/2/2022 | $502,279 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 000 | 19 | NIH | 11/10/2022 | $381,159 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI166693 | Legacy of Obesity on Influenza and Coronavirus | 000 | 2 | NIH | 10/20/2022 | $91,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI166434 | Astrovirus CNS Infections | 000 | 2 | NIH | 10/28/2022 | $91,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM112846 | The role of weak multivalent interactions and phase separation in SPOP tumor suppressor function | 000 | 9 | NIH | 12/2/2022 | $323,100 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM135599 | Structural and functional studies of chromatin modifiers | 000 | 4 | NIH | 11/30/2022 | $339,255 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA246125 | Role of Phase separation by fusion oncoproteins in oncogenesis | 000 | 4 | NIH | 11/30/2022 | $562,765 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS097974 | Dynamic RNA-protein assemblies and neurological disease | 000 | 7 | NIH | 11/28/2022 | $897,500 |
| | 2023 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 001 | 28 | NIH | 12/1/2022 | $876,868 |
| | 2023 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R61CA280978 | Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma | 000 | 1 | NIH | 10/11/2022 | $0 |
| | 2023 | 2021 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 000 | 27 | NIH | 12/1/2022 | -$63,068 |
| | 2023 | 2021 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | F32GM143847 | Probing the prevalence and molecular mechanisms of phase separation by fusion oncoproteins | 000 | 1 | NIH | 10/27/2022 | -$18,026 |
| | 2023 | 2021 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R56AI155614 | Consequences of Direct Viral-Bacterial Interactions | 000 | 1 | NIH | 11/23/2022 | $0 |
| | 2023 | 2021 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | F32HL154636 | Functional evaluation of clonal hematopoiesis of indeterminate potential (CHIP) | 000 | 2 | NIH | 10/26/2022 | -$1,656 |
| | 2023 | 2020 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01HL112792 | Aberrant megakaryopoiesis in the myleoproliferative neoplasms | 000 | 9 | NIH | 11/14/2022 | -$33,783 |
| | 2023 | 2020 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG053987 | Multi-level Integrative Proteomics to Alzheimer's Disease Pathways | 000 | 5 | NIH | 11/8/2022 | -$19,304 |
| | 2023 | 2020 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA194206 | Transporters and hematopoietic toxicity | 000 | 5 | NIH | 10/31/2022 | $0 |
| | 2023 | 2018 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI111449 | Development of Aminospectinomycins for Biodefense | 000 | 5 | NIH | 10/17/2022 | $0 |
| | 2023 | 2017 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS037956 | ATM and DNA Damage in the Nervous System | 000 | 18 | NIH | 10/1/2022 | -$109,374 |
|
| Issue Date FY: 2022 ( Subtotal = $89,501,401 ) (Continued on the next page) |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI159289 | A genetic switch to study the causal roles of T cell repertoire diversity | 000 | 1 | NIH | 1/5/2022 | $91,000 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 1 | NIH | 1/5/2022 | $522,779 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA260175 | XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION | 000 | 1 | NIH | 3/3/2022 | $416,325 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | F32HL164095 | Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells | 002 | 1 | NIH | 7/16/2022 | $0 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | F32HL164095 | Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells | 001 | 1 | NIH | 7/16/2022 | $1,192 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | F32HL164095 | Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells | 000 | 1 | NIH | 3/10/2022 | $66,390 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI166434 | Astrovirus CNS Infections | 000 | 1 | NIH | 10/25/2021 | $91,000 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35CA253096 | Identifying the mechanisms of leukemia progression | 000 | 2 | NIH | 8/5/2022 | $1,055,460 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA264610 | Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia | 002 | 2 | NIH | 9/13/2022 | $0 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA264610 | Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia | 001 | 2 | NIH | 8/12/2022 | $700,050 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM142772 | Exploiting Water Network Perturbations in Protein Binding Sites | 000 | 2 | NIH | 5/11/2022 | $448,649 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24NS120854 | ClinGen Expert Curation Panel for the Epilepsies | 000 | 2 | NIH | 7/14/2022 | $376,324 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS119760 | Understanding the developmental progression of subpallial neural progenitor cells | 001 | 2 | NIH | 7/5/2022 | $448,750 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03HD104066 | The Genetic Study of Families with a High Frequency of Hematopoietic Malignancy | 000 | 2 | NIH | 4/21/2022 | $179,500 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS123116 | Interneuron circuits in the spinal motor system | 000 | 2 | NIH | 5/9/2022 | $448,750 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI160179 | Regulation of lung inflammatory and antiviral responses during coronavirus infection | 001 | 2 | NIH | 8/19/2022 | $393,437 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI160179 | Regulation of lung inflammatory and antiviral responses during coronavirus infection | 000 | 2 | NIH | 5/16/2022 | $763,801 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141357 | Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | 001 | 2 | NIH | 6/21/2022 | $35,900 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141357 | Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | 000 | 2 | NIH | 2/8/2022 | $323,100 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121249 | Improving genetically engineered T cells for medulloblastomas | 001 | 2 | NIH | 4/20/2022 | $44,478 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121249 | Improving genetically engineered T cells for medulloblastomas | 000 | 2 | NIH | 3/1/2022 | $400,297 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141694 | Chromatin of repetitive elements | 001 | 2 | NIH | 6/23/2022 | $35,900 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141694 | Chromatin of repetitive elements | 000 | 2 | NIH | 3/22/2022 | $323,100 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI163942 | Identify novel modulators of regulatory T cell function from the dynamic cis-proteomes | 000 | 2 | NIH | 5/20/2022 | $224,375 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM138293 | Computational tools for estimating cell-type-specific effects in bulk RNA-seq and spatial transcriptomics data, using reference single-cell RNA-seq datasets | 000 | 3 | NIH | 6/1/2022 | $436,750 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA264837 | Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia | 000 | 2 | NIH | 7/6/2022 | $587,189 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35CA253188 | Integrating systems immunology with immunometabolism and cancer immunity | 000 | 2 | NIH | 7/1/2022 | $1,055,460 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA263969 | In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas | 001 | 2 | NIH | 6/24/2022 | $752,016 |
| | 2022 | 2022 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS116361 | Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma | 001 | 2 | NIH | 9/5/2022 | $576,139 |
|
